These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31870133)

  • 1. The Tumor Suppressor, p53, Negatively Regulates Non-Canonical NF-κB Signaling through miRNAInduced Silencing of NF-κB-Inducing Kinase.
    Jang H; Park S; Kim J; Kim JH; Kim SY; Cho S; Park SG; Park BC; Kim S; Kim JH
    Mol Cells; 2020 Jan; 43(1):23-33. PubMed ID: 31870133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-canonical NF-κB signaling pathway.
    Sun SC
    Cell Res; 2011 Jan; 21(1):71-85. PubMed ID: 21173796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
    Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of p53 and Rb links the alternative NF-κB pathway to EZH2 expression and cell senescence.
    Iannetti A; Ledoux AC; Tudhope SJ; Sellier H; Zhao B; Mowla S; Moore A; Hummerich H; Gewurz BE; Cockell SJ; Jat PS; Willmore E; Perkins ND
    PLoS Genet; 2014 Sep; 10(9):e1004642. PubMed ID: 25255445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis.
    Gray CM; McCorkell KA; Chunduru SK; McKinlay MA; May MJ
    Biochem Biophys Res Commun; 2014 Jul; 450(1):341-6. PubMed ID: 24942881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations.
    Bhattacharyya S; Borthakur A; Dudeja PK; Tobacman JK
    Exp Cell Res; 2010 Nov; 316(19):3317-27. PubMed ID: 20466000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway.
    Mukherjee T; Ratra Y; Banoth B; Deka A; Polley S; Basak S
    Methods Mol Biol; 2021; 2366():165-181. PubMed ID: 34236638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation.
    Kucharzewska P; Maracle CX; Jeucken KCM; van Hamburg JP; Israelsson E; Furber M; Tas SW; Olsson HK
    J Cell Sci; 2019 Apr; 132(7):. PubMed ID: 30837284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.
    Al-Sadi R; Guo S; Ye D; Rawat M; Ma TY
    Am J Pathol; 2016 May; 186(5):1151-65. PubMed ID: 26948423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha).
    Yamaguchi T; Kimura J; Miki Y; Yoshida K
    J Biol Chem; 2007 Nov; 282(47):33943-8. PubMed ID: 17897950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB.
    Liu Z; Mar KB; Hanners NW; Perelman SS; Kanchwala M; Xing C; Schoggins JW; Alto NM
    Nature; 2019 Apr; 568(7751):249-253. PubMed ID: 30894749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
    Farhana L; Dawson MI; Murshed F; Fontana JA
    Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling.
    Sun SC
    Sci Signal; 2010 May; 3(123):pe18. PubMed ID: 20501935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.
    Sfikas A; Batsi C; Tselikou E; Vartholomatos G; Monokrousos N; Pappas P; Christoforidis S; Tzavaras T; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
    Cell Signal; 2012 Nov; 24(11):2007-23. PubMed ID: 22750558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB inducing kinase, NIK mediates cigarette smoke/TNFα-induced histone acetylation and inflammation through differential activation of IKKs.
    Chung S; Sundar IK; Hwang JW; Yull FE; Blackwell TS; Kinnula VL; Bulger M; Yao H; Rahman I
    PLoS One; 2011; 6(8):e23488. PubMed ID: 21887257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
    Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
    Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100.
    Qing G; Qu Z; Xiao G
    J Biol Chem; 2005 Dec; 280(49):40578-82. PubMed ID: 16223731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the atypical NF-κB pathway induced by ionizing radiation is not affected by the p53 status.
    Zając G; Rusin M; Łasut-Szyszka B; Puszyński K; Widłak P
    Acta Biochim Pol; 2022 Feb; 69(1):205-210. PubMed ID: 35130377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB.
    Huang WC; Ju TK; Hung MC; Chen CC
    Mol Cell; 2007 Apr; 26(1):75-87. PubMed ID: 17434128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.